Found: 11
Select item for more details and to access through your institution.
A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
- Published in:
- Neurogastroenterology & Motility, 2015, v. 27, n. 6, p. 805, doi. 10.1111/nmo.12553
- By:
- Publication type:
- Article
Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
- Published in:
- Neurogastroenterology & Motility, 2015, v. 27, n. 3, p. 397, doi. 10.1111/nmo.12505
- By:
- Publication type:
- Article
Effect of prucalopride on symptoms of chronic constipation.
- Published in:
- Neurogastroenterology & Motility, 2014, v. 26, n. 1, p. 21, doi. 10.1111/nmo.12217
- By:
- Publication type:
- Article
A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation.
- Published in:
- Neurogastroenterology & Motility, 2010, v. 22, n. 9, p. 991, doi. 10.1111/j.1365-2982.2010.01533.x
- By:
- Publication type:
- Article
Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study.
- Published in:
- Neurogastroenterology & Motility, 2009, v. 21, n. 12, p. 1256, doi. 10.1111/j.1365-2982.2009.01398.x
- By:
- Publication type:
- Article
Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2002, v. 16, n. 4, p. 759, doi. 10.1046/j.1365-2036.2002.01210.x
- By:
- Publication type:
- Article
The PAC- SYM questionnaire for chronic constipation: defining the minimal important difference.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1103, doi. 10.1111/apt.14349
- By:
- Publication type:
- Article
Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 1, p. 48, doi. 10.1111/j.1365-2036.2011.04907.x
- By:
- Publication type:
- Article
Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 9, p. 1113, doi. 10.1111/j.1365-2036.2010.04455.x
- By:
- Publication type:
- Article
Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 29, n. 3, p. 315, doi. 10.1111/j.1365-2036.2008.03884.x
- By:
- Publication type:
- Article
P.045 Safety profile overview of Efgartigimod Clinical Trials in participants with diverse Diverse IgG-Mediated Autoimmune Diseases.
- Published in:
- 2023
- By:
- Publication type:
- Abstract